Sodium salicylamide: relative bioavailability and subjective effects

Area of Science:

• Pharmacokinetics and Drug Delivery
• Clinical Pharmacology

Background:

• Salicylamide (SAM) is a medication with established therapeutic uses.
• Understanding the bioavailability of different dosage forms is crucial for optimizing drug efficacy.

Purpose of the Study:

• To compare the bioavailability of sodium salicylamide (NaSAM) in solution versus salicylamide (SAM) in tablet form.
• To assess the dose-dependency and pharmacokinetic profiles of both NaSAM and SAM.
• To evaluate the onset and intensity of sedative effects associated with each dosage form.

Main Methods:

• A comparative bioavailability study involving 6 healthy human volunteers.
• Oral administration of varying doses (0.65 to 2.60 gm) of NaSAM liquid and SAM tablets.
• Plasma level determination of free and total salicylamide over 3 hours post-administration.
• Assessment of subjective sedative effects using a self-scoring questionnaire.

Main Results:

• NaSAM demonstrated dose-dependent and superior bioavailability compared to SAM tablets.
• Higher peak plasma levels of both free and total salicylamide were achieved earlier with NaSAM.
• Significantly greater concentrations of free and total SAM were observed with NaSAM at higher doses.
• Sedative effects and side effects like lightheadedness occurred earlier and were more pronounced with NaSAM.

Conclusions:

• Sodium salicylamide in liquid solution represents a potentially superior dosage form due to enhanced bioavailability and faster onset of action.
• The findings suggest NaSAM may offer improved therapeutic outcomes compared to traditional SAM tablets.
• Further investigation into NaSAM's clinical utility is warranted based on its pharmacokinetic advantages.